Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Travis Jeannotte
Introduction
Travis Jeannotte is a notable inventor based in Nashua, NH (US). He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid encapsulation. His work has implications for various applications, including drug delivery and genetic therapies.
Latest Patents
Travis Jeannotte holds 1 patent for a method of encapsulating a nucleic acid in a lipid nanoparticle host. This innovative technique involves producing encapsulated nucleic acid nanoparticles of uniformly small particle size by intersecting one or more nucleic acid streams with one or more lipid streams. The resulting nanoparticles include a nucleic acid encapsulated within a lipid nanoparticle host. This method ensures that uniformly small particle sizes are achieved by intersecting an aqueous nucleic acid stream and a stream of lipids in organic solvent at high linear velocities, with total organic solvent concentrations less than 33%.
Career Highlights
Travis Jeannotte is currently employed at Novartis AG, a leading global healthcare company. His role at Novartis allows him to further develop his innovative ideas and contribute to advancements in medical science. His expertise in lipid nanoparticle technology positions him as a valuable asset in the field.
Collaborations
Travis has collaborated with notable colleagues, including Keith Bowman and Noah Gardner. These partnerships enhance the research and development efforts within his team, fostering an environment of innovation and creativity.
Conclusion
Travis Jeannotte's work exemplifies the spirit of innovation in biotechnology. His patented method for encapsulating nucleic acids in lipid nanoparticles represents a significant advancement in the field. Through his contributions at Novartis AG, he continues to push the boundaries of what is possible in medical science.